首页> Cureus> Efficacy and Safety of Folisurge, a Biosimilar Recombinant Follicle-Stimulating Hormone, Versus Gonal-F in Assisted Reproductive Technology Practice in India: A Real-World Study.

Efficacy and Safety of Folisurge, a Biosimilar Recombinant Follicle-Stimulating Hormone, Versus Gonal-F in Assisted Reproductive Technology Practice in India: A Real-World Study.

导出 LinkOut

翻译打印收藏纠错

第一作者： Shashank,Sanagoudar

第一单位： Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Udaipur, IND.

作者： Shashank,Sanagoudar ^[1] ; Vipin,Chandra ^[2] ; Shipra,Nigam ^[3] ; Anjali,Gahalan ^[4] ; Ritu,Punhani ^[5] ; Nihita,Pandey ^[6] ; Sara,Zaidi ^[7] ; Jyoti,Panday ^[8] ; Nihar Ranjan,Bhoi ^[1] ; Walmik,Mistari ^[9] ; Isha,Suwalka ^[10] ; Nitasha,Gupta ^[1]

作者单位： Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Udaipur, IND. ^[1] Department of Clinical Research and Operations, Indira IVF Hospital Private Limited, Udaipur, IND. ^[2] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Shahdara, IND. ^[3] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Allahabad, IND. ^[4] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, New Delhi, IND. ^[5] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Kolkata, IND. ^[6] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Dadar, IND. ^[7] Department of Reproductive Medicine, Indira IVF Hospital Private Limited, Ghaziabad, IND. ^[8] Department of Clinical Lab and Operations, Indira IVF Hospital Private Limited, Udaipur, IND. ^[9] Department of Research and Publication, Indira IVF Hospital Private Limited, Udaipur, IND. ^[10]

关键词 antral follicle count (afc)assisted reproductive technology (art)body mass index (bmi)controlled ovarian stimulation (cos)recombinant human follicle-stimulating hormone (r-hfsh)serum anti-mullerian hormone

DOI 10.7759/cureus.98622

PMID 41503299

发布时间 2026-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cureus

2025年17卷12期

e98622页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Cureus

2025年17卷12期

e98622页

检索历史清除

Efficacy and Safety of Folisurge, a Biosimilar Recombinant Follicle-Stimulating Hormone, Versus Gonal-F in Assisted Reproductive Technology Practice in India: A Real-World Study.

Cureus

相似文献

同项目论文

Cureus

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Efficacy and Safety of Folisurge, a Biosimilar Recombinant Follicle-Stimulating Hormone, Versus Gonal-F in Assisted Reproductive Technology Practice in India: A Real-World Study.

Cureus

相似文献

同项目论文

Cureus

相关期刊

检索历史清除